Invention Application
- Patent Title: IMMUNOMODULATORS
-
Application No.: US15475227Application Date: 2017-03-31
-
Publication No.: US20170283463A1Publication Date: 2017-10-05
- Inventor: Michael Matthew Miller , Martin Patrick Allen , Ling Li , Michael S. Bowsher , Eric P. Gillis , Eric Mull , Qian Zhao , Li-Qiang Sun , David R. Langley , Paul Michael Scola
- Applicant: Bristol-Myers Squibb Company
- Main IPC: C07K7/56
- IPC: C07K7/56
Abstract:
The present disclosure provides novel macrocyclic peptides which inhibit the PD-1/PD-L1 and PD-L1/CD80 protein/protein interaction, and thus are useful for the amelioration of various diseases, including cancer and infectious diseases.
Public/Granted literature
- US10358463B2 Immunomodulators Public/Granted day:2019-07-23
Information query
